Edgar N Tafaleng1, Michelle R Malizio2, Ira J Fox1,3,4, Alejandro Soto-Gutierrez2,3,4. 1. Department of Surgery. 2. Department of Pathology, University of Pittsburgh School of Medicine. 3. Pittsburgh Liver Research Center, University of Pittsburgh. 4. McGowan Institute for Regenerative Medicine, Pittsburgh, Pennsylvania, USA.
Abstract
PURPOSE OF REVIEW: In this review, we will explore recent advances in human induced pluripotent stem cell (iPSC)-based modeling of metabolic liver disease and biofabrication of synthetic human liver tissue while also discussing the emerging concept of synthetic biology to generate more physiologically relevant liver disease models. RECENT FINDING: iPSC-based platforms have facilitated the study of underlying cellular mechanisms and potential therapeutic strategies for a number of metabolic liver diseases. Concurrently, rapid progress in biofabrication and gene editing technologies have led to the generation of human hepatic tissue that more closely mimic the complexity of the liver. SUMMARY: iPSC-based liver tissue is rapidly becoming available for modeling liver physiology due to its ability to recapitulate the complex three-dimensional architecture of the liver and recapitulate interactions between the different cell types and their surroundings. These mini livers have also been used to recapitulate liver disease pathways using the tools of synthetic biology, such as gene editing, to control gene circuits. Further development in this field will undoubtedly bolster future investigations not only in disease modeling and basic research, but also in personalized medicine and autologous transplantation.
PURPOSE OF REVIEW: In this review, we will explore recent advances in human induced pluripotent stem cell (iPSC)-based modeling of metabolic liver disease and biofabrication of synthetic human liver tissue while also discussing the emerging concept of synthetic biology to generate more physiologically relevant liver disease models. RECENT FINDING: iPSC-based platforms have facilitated the study of underlying cellular mechanisms and potential therapeutic strategies for a number of metabolic liver diseases. Concurrently, rapid progress in biofabrication and gene editing technologies have led to the generation of human hepatic tissue that more closely mimic the complexity of the liver. SUMMARY: iPSC-based liver tissue is rapidly becoming available for modeling liver physiology due to its ability to recapitulate the complex three-dimensional architecture of the liver and recapitulate interactions between the different cell types and their surroundings. These mini livers have also been used to recapitulate liver disease pathways using the tools of synthetic biology, such as gene editing, to control gene circuits. Further development in this field will undoubtedly bolster future investigations not only in disease modeling and basic research, but also in personalized medicine and autologous transplantation.
Authors: Max A Cayo; Sunil K Mallanna; Francesca Di Furio; Ran Jing; Lauren B Tolliver; Matthew Bures; Amanda Urick; Fallon K Noto; Evanthia E Pashos; Matthew D Greseth; Maciej Czarnecki; Paula Traktman; Wenli Yang; Edward E Morrisey; Markus Grompe; Daniel J Rader; Stephen A Duncan Journal: Cell Stem Cell Date: 2017-04-06 Impact factor: 24.633
Authors: Max A Cayo; Jun Cai; Ann DeLaForest; Fallon K Noto; Masato Nagaoka; Brian S Clark; Ross F Collery; Karim Si-Tayeb; Stephen A Duncan Journal: Hepatology Date: 2012-09-17 Impact factor: 17.425
Authors: Su Mi Choi; Yonghak Kim; Joong Sup Shim; Joon Tae Park; Rui-Hong Wang; Steven D Leach; Jun O Liu; Chuxia Deng; Zhaohui Ye; Yoon-Young Jang Journal: Hepatology Date: 2013-06 Impact factor: 17.425
Authors: Le Cong; F Ann Ran; David Cox; Shuailiang Lin; Robert Barretto; Naomi Habib; Patrick D Hsu; Xuebing Wu; Wenyan Jiang; Luciano A Marraffini; Feng Zhang Journal: Science Date: 2013-01-03 Impact factor: 47.728
Authors: Mihaela Zabulica; Raghuraman C Srinivasan; Pinar Akcakaya; Gabriella Allegri; Burcu Bestas; Mike Firth; Christina Hammarstedt; Tomas Jakobsson; Towe Jakobsson; Ewa Ellis; Carl Jorns; Georgios Makris; Tanja Scherer; Nicole Rimann; Natalie R van Zuydam; Roberto Gramignoli; Anna Forslöw; Susanna Engberg; Marcello Maresca; Olav Rooyackers; Beat Thöny; Johannes Häberle; Barry Rosen; Stephen C Strom Journal: Mol Ther Date: 2021-01-21 Impact factor: 11.454